SCHEMBL8467103

SCHEMBL8467103

COC(=O)Cc1ccc([N+](C)(C)C)c(F)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.49
GAA P10253 1/20 0.49
GFER P55789 1/20 0.49
CYP4F2 P78329 1/20 0.46
CYP4A11 Q02928 1/20 0.46
HSP90AB1 P08238 1/20 0.45
HPGD P15428 2/20 0.43
MAPT P10636 1/20 0.43
TSHR P16473 1/20 0.43
PDK2 Q15119 1/20 0.42
SLC7A5 Q01650 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 4/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
PKM P14618 1/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30639470 0.82 ALDH1A1 (0.56) ALDH1A1GAAGFERCYP4F2CYP4A11
SCHEMBL1717077 0.82 ALDH1A1 (0.56) ALDH1A1GAAGFERCYP4F2CYP4A11
SCHEMBL8448707 0.81 ALDH1A1 (0.46) ALDH1A1GAAGFERCYP4F2CYP4A11
SCHEMBL8454171 0.79 ALDH1A1 (0.47) ALDH1A1GAAGFERCYP4F2CYP4A11
SCHEMBL30154442 0.79 GAA (0.66) ALDH1A1GAAGFERCYP4F2CYP4A11
SCHEMBL1555409 0.79 ALDH1A1 (0.53) ALDH1A1GAAGFERCYP4F2CYP4A11
SCHEMBL926809 0.79 GAA (0.66) ALDH1A1GAAGFERCYP4F2CYP4A11
SCHEMBL24410145 0.78 ALDH1A1 (0.51) ALDH1A1GAAGFERCYP4F2CYP4A11
SCHEMBL1039522 0.78 HTT (0.51) ALDH1A1GAAGFERCYP4F2CYP4A11
SCHEMBL5957236 0.78 ALDH1A1 (0.64) ALDH1A1GAAGFERCYP4F2CYP4A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2455105-A2 Bombesin analogues Bayer Pharma Aktiengesellschaft (DE) 2012-05-23 EP disclosed
EP-2289564-A2 Derivatives of aniline as precursors for F18-labeling Bayer Schering Pharma Aktiengesellschaft (DE) 2011-03-02 EP disclosed
EP-2279759-A2 Compounds and methods for 18F labeled agents Bayer Schering Pharma Aktiengesellschaft (DE) 2011-02-02 EP disclosed
EP-1985624-A2 Single step method of radiofluorination of biologically active compounds or biomolecules Bayer Schering Pharma Aktiengesellschaft (DE) 2008-10-29 EP disclosed
WO-2008028688-A2 COMPOUNDS AND METHODS FOR 18F LABELED AGENTS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-03-13 WO disclosed